Paolini John F. bought KNSA
May 1, 2026 · Form 4 insider transaction
Paolini John F. bought 58,424 shares of Kiniksa Pharmaceuticals International, plc at $10.36 per share, a transaction worth $605.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,424
Price
$10.36
Total value
$605.3K
InsiderPaolini John F.
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after124,047
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on November 18, 2025.